Mitochondria‐Targeted Chemodynamic Nanoagent Synergizes With Transcriptional Modulation for Enhanced Pyroptosis Immunotherapy
Small · 2026
DOI: 10.1002/smll.75156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Rujiang Ao und 12 weiteren Autor:innen. Beteiligte Einrichtung: New Cornerstone Science Laboratory, MOE Key Laboratory For Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fu…. Hauptthemen laut MEDLINE: Pyroptosis, Mitochondria, Immunotherapy, Nanoparticles. Die Arbeit nennt 79 Literaturangaben. Gefördert von: National Natural Science Foundation of China, New Cornerstone Science Foundation.
Abstract (Originalsprache)
Pyroptosis represents an important pathway to initiate immunogenic cell death (ICD) mediated by N‐terminal fragment of gasdermin E (GSDME‐N). Although chemodynamic therapy (CDT) has the potential to elicit pyroptosis, epigenetic silencing of gasdermin E (GSDME) in tumor cells commonly shifts cell fate toward immunologically silent apoptosis. Herein, we develop a mitochondria‐targeted CDT agent (Mito‐CA/TA NPs) that incorporates tetrachloro‐p‐benzoquinone (chloranil, CA) with transcriptional regulator triamcinolone acetonide (TA) for enhanced pyroptosis immunotherapy. The encapsulated CA facilitates chemodynamic conversion of intramitochondrial hydrogen peroxide (H 2 O 2 ) into hydroxyl radicals (•OH) under physiological pH, surmounting the acidic constraint of classical Fenton chemistry‐based CDT. Simultaneously, H 2 O 2 ‐induced hydrophilic transformation of CA ensures TA release to rescue GSDME downregulation in cancer cells, reversing epigenetic silencing of GSDME. Intramitochondrial •OH generation by Mito‐CA/TA NPs in situ disrupts mitochondrial integrity, leading to cytochrome c release and subsequent caspase‐3 activation, which causes the proteolytic cleavage of transcriptionally upregulated GSDME into GSDME‐N. Additionally, integrating •OH‐responsive chemiluminescent functionality into Mito‐CA/TA NPs enables real‐time monitoring of •OH formation and chemodynamic immunotherapeutic processes. The coordinated action of GSDME restoration and in situ mitochondrial •OH generation potently triggers pyroptosis to stimulate systemic antitumor immune responses, offering a universal strategy for improving pyroptosis‐based cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- New Cornerstone Science Laboratory, MOE Key Laboratory For Analytical Science of Food Safety and Biology, College of Chemistry, Fuzhou University, Fuzhou, People's Republic of China.
- Department of Neurosurgery, Neurosurgery Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, People's Republic of China.
- Departments of Diagnostic Radiology, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singapore, Singapore.
ORCID-Profile: Rujiang Ao, Yang Zhu, Huilan Cai, Lisen Lin, Huanghao Yang
Förderung
- National Natural Science Foundation of China
- New Cornerstone Science Foundation
Zitieren
APA
Ao, R., Guo, J., Chen, S., Zhu, Y., Cai, H., Niu, X., Cui, T., Yu, M., Wang, J., Huang, H., Peng, S., Lin, L., & Yang, H. (2026). Mitochondria‐Targeted Chemodynamic Nanoagent Synergizes With Transcriptional Modulation for Enhanced Pyroptosis Immunotherapy. Small. https://doi.org/10.1002/smll.75156
Vancouver
Ao R, Guo J, Chen S, Zhu Y, Cai H, Niu X, et al. Mitochondria‐Targeted Chemodynamic Nanoagent Synergizes With Transcriptional Modulation for Enhanced Pyroptosis Immunotherapy. Small. 2026. doi:10.1002/smll.75156
BibTeX
@article{Ao2026,
author = {Ao, Rujiang and Guo, Jingyi and Chen, Sixue and Zhu, Yang and Cai, Huilan and Niu, Xuegang and Cui, Tingting and Yu, Meili and Wang, Jun and Huang, Hongwei and Peng, Shanshan and Lin, Lisen and Yang, Huanghao},
title = {Mitochondria‐Targeted Chemodynamic Nanoagent Synergizes With Transcriptional Modulation for Enhanced Pyroptosis Immunotherapy},
journal = {Small},
year = {2026},
doi = {10.1002/smll.75156}
}
EUVIMED